Home-based care coordination for dementia patients
A Comprehensive Care Coordination and Management Platform for Alzheimer's Disease and Related Dementia (Care4AD)
PHASE1; PHASE2 · Baylor College of Medicine · NCT04308512
This study is testing a new device called Care4AD to see if it helps caregivers manage daily activities better for people with mild to moderate Alzheimer's Disease.
Quick facts
| Phase | PHASE1; PHASE2 |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 65 Years and up |
| Sex | All |
| Sponsor | Baylor College of Medicine (other) |
| Locations | 2 sites (Houston, Texas and 1 other locations) |
| Trial ID | NCT04308512 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a home-based care coordination device called Care4AD, designed to assist caregivers in managing dementia care. It involves a 6-month randomized control trial with 100 participants who have mild to moderate Alzheimer's Disease. The intervention group will receive reminders and support through the device, while the control group will not. The study aims to measure changes in caregiver burden, patient adherence to daily activities, and overall physical activity levels. Additionally, the acceptability and ease of use of the Care4AD system will be assessed.
Who should consider this trial
Good fit: Ideal candidates are older adults over 65 years with mild to moderate Alzheimer's Disease who are ambulatory and live at home with a caregiver.
Not a fit: Patients with severe dementia, immobility, or significant medical conditions that hinder participation may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce caregiver stress and improve the quality of life for both caregivers and individuals with dementia.
How similar studies have performed: Other studies have shown promise in using technology for dementia care coordination, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria include: * Older patients (\> 65 years old) with mild or moderate Alzheimer's Disease * Must be ambulatory * Must be in a residential home with a caregiver/informant. Exclusion Criteria: * Immobility or inability to engage in activities that are essential for independent living (e.g., patients with severe dementia); * Any significant medical or psychiatric condition that, in the judgment of the investigators, would potentially interfere with the ability to participate in the study * Major hearing/visual impairment; * Residing in a nursing home or are receiving hospice care; * Inability to communicate in English or Spanish; * Unavailability or unwillingness of the caregiver of the patient to attend the interview.
Where this trial is running
Houston, Texas and 1 other locations
- Baylor College of Medicine — Houston, Texas, United States (ACTIVE_NOT_RECRUITING)
- Baylor College of Medicine — Houston, Texas, United States (RECRUITING)
Study contacts
- Study coordinator: Maria Noun, BS
- Email: maria.noun@bcm.edu
- Phone: 713-798-7538
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Alzheimer Disease, Dementia, Dementia Alzheimers, Alzheimber, care coordination